The Edit Review (2026): $209 Semaglutide, Checked

The first thing to fix about The Edit (theedithealth.com) is the number in your head. If you arrived from an ad, that number is $109. The standing price for its compounded semaglutide is $209 a month, and $109 is a $100-off promotion that applies to a first order and then stops.¹ Getting that out of the way first is worth doing, because almost everything else about this operator's pricing turned out to be unusually straight — and the promotional headline is the one part of it that would mislead you.

We looked at The Edit in August 2026, as one of seven telehealth sellers screened in the same pass. Prices below are the published ones, read off the provider's own product surfaces. Verify before you pay; nothing here is medical or financial advice, and we earn nothing whichever way you go.

The semaglutide rung

$209 a month, month to month, with no separate membership fee and cancellation taking effect at the end of the period you have already paid for.¹ That is the recurring rate — the one you will still be paying in month four, which is the only figure worth budgeting against.

It is not a cheap number. On the semaglutide market as a whole it sits comfortably in the upper half, and our price-ordered semaglutide board will show you exactly where. What it is, is a number that stayed the same everywhere we looked for it.

Prepay, and why the division matters

Two prepay rungs are offered: $575 once for three months and $1,065 once for six. The Edit prints those as $192 and $178 a month respectively, and both divisions are exact — 575 ÷ 3 is 191.67, 1,065 ÷ 6 is 177.50.¹ Each is labelled "billed once at the start of the plan", so nothing is being passed off as a recurring charge that is really a lump sum.

That sounds like faint praise until you notice how often it goes the other way. A prepay total quoted as a monthly rate is the single most common reason a provider lands at the bottom of a cost comparison it has no business winning, and it is the trap our Wegovy and Ozempic cost calculator exists to defuse. The Edit does not set it.

Tirzepatide and the rest of the shelf

Tirzepatide is $309 a month, with prepay at $855 for three months ($285 a month) and $1,575 for six ($263 a month) — the same structure, the same honest arithmetic.¹ If you are weighing the two molecules rather than the two prices, start with semaglutide versus tirzepatide and come back with a decision already made.

Beyond the GLP-1 line there are four more protocols, all priced monthly: NAD+ at $249, glutathione at $199, sermorelin at $169, and a GHK-Cu topical cream at $129.¹ There is no oral GLP-1 and no nasal line, and the site states in its own words that it does not sell research-use-only compounds. That sentence is worth more than it reads. A large share of this market runs an investigational shelf alongside the prescription one, and the absence of it here is a deliberate choice someone made.

Who compounds it, and who signs for it

Two questions decide whether a compounded semaglutide seller is answerable to anyone: which pharmacy fills it, and which clinician's licence is attached to the prescription. The Edit answers both. Dispensing is attributed to The Pharmacy Hub, named rather than described as an unnamed partner. The prescribing organisation is Arora Health & Aesthetics, LLC, whose medical director is Dr. Sean Arora; his NPI, 1841729449, resolves in the national provider registry to an active Family Medicine record in Seattle, Washington.² That is a claim you can check in about ninety seconds, which is the whole point of publishing it.

One caveat before you treat this as a second opinion on anything: Trellis Vitality runs on the same medical group and the same medical director. Different pharmacy, different prices, genuinely different products — but shortlisting both is shortlisting one clinical organisation twice.

The Spanish site is an actual site

The Edit ships a complete Spanish mirror: every page, 33 Spanish URLs declared in its own sitemap. Most operators translate a landing page and leave the intake, the dosing instructions and the cancellation policy in English. If Spanish is the language you want your injection instructions in — and injection technique is where compounded vials go wrong — that is a material difference rather than a marketing one.

The regulatory screen

We queried the FDA's live warning-letter index in August 2026 for the trading name, the legal entity, the medical group and the named pharmacy. None returned a match in the company column.³ That result carries weight only because the same pass, run the same way, correctly returned a known February 2026 letter for an unrelated telehealth seller used as a control — an empty result from a broken query looks exactly like a clean record, and this one was not empty by accident.

What we could not check

We could not reach a checkout. The intake is questionnaire-gated and its scripts carry no price table, so the ladder above is the published ladder — corroborated across two independent surfaces on the provider's own site rather than confirmed at the point of sale.

Compounded medication is final sale once shipped, which is standard for the category and explained in is compounded semaglutide still legal in 2026?. Starting is free: the site states there is no charge and no card on file to begin, and a full refund if you are not approved.

Where it lands

If what you want is a semaglutide price that will still be the same price in month four, The Edit is the most reliable of the seven sellers in this batch. It is not the cheapest of them — Pepti advertises $99, Trellis publishes $150 and Auren Rx sells a no-commitment month at $199. It is the one whose published figures survived every arithmetic check we ran, named its pharmacy, and gave us an NPI to verify.

Read it against the rest of the programs we track, and against the standing question of whether the money is worth it at your number.